Cargando…
The validation of artificial anti‐monkeypox antibodies by in silico and experimental approaches
As a result of smallpox immunization programs that ended more than 40 years ago, a significant portion of the world's population is not immune. Moreover, due to the lack of anti‐monkeypox drugs and vaccines against monkeypox, the spread of this virus may be the beginning of another challenge. I...
Autores principales: | Shabani, Sadeq, Rashidi, Mohsen, Radgoudarzi, Shakila, Jebali, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091375/ https://www.ncbi.nlm.nih.gov/pubmed/37102640 http://dx.doi.org/10.1002/iid3.834 |
Ejemplares similares
-
Multi-Epitope-Based Vaccine Candidate for Monkeypox: An In Silico Approach
por: Abdi, Sayed Aliul Hasan, et al.
Publicado: (2022) -
In Silico Repurposed Drugs against Monkeypox Virus
por: Lam, Hilbert Yuen In, et al.
Publicado: (2022) -
Artificial Neural Networks for the Prediction of Monkeypox Outbreak
por: Manohar, Balakrishnama, et al.
Publicado: (2022) -
In-silico primer designing and PCR for detection of monkeypox virus (MPXV)
por: Khoo, Ying Wei, et al.
Publicado: (2022) -
In silico Selection and Experimental Validation of FDA-Approved Drugs as Anti-quorum Sensing Agents
por: Mellini, Marta, et al.
Publicado: (2019)